Promoting Mental and Physical Well-being Through Smart Health
Promoting and Supporting Mental and Physical Well-being: the Role of Smart Health in the Prevention of Cerebrocardiovascular Disease
1 other identifier
observational
40
1 country
1
Brief Summary
The objective of the study is to develop a smartphone application dedicated to health prevention in terms of monitoring physical activity and healthy eating, mediated by the use of Mindfulness-ACT exercises to reduce unhealthy lifestyles and monitoring through the use of engineered wearable bands. This is a nonpharmacological prospective observational study. The procedure includes consecutive enrollment in the study of 40 subjects who meet all inclusion criteria. Patients will undergo comprehensive cognitive assessment with collection of all medical history data and information on current clinical condition, including dietary lifestyle. After that they will be invited to register on Brainhearth platform, and then via the app monitoring of physical activity and nutrition, mediated by the use of Mindfulness-ACT exercises, will take place.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
March 13, 2023
CompletedFirst Posted
Study publicly available on registry
March 27, 2023
CompletedMarch 27, 2023
March 1, 2023
5 months
March 13, 2023
March 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Mindfulness Awareness Attention Scale MAAS
The Mindfulness Awareness Attention Scale measures an individual's tendency for mindfulness in an intentional way, based on the frequency in which he or she is mind-ful or mind-less in his or her experiences.
15 DAYS
Study Arms (2)
Group 1
All patients are assessed. The neuropsychologist assessed global cognitive status and disposition to Mindfulness. Engineered bands for multi-parameter heart rate monitoring were delivered.From the time of delivery, for 9 consecutive days the patient received a reminder via WhatsApp at the most convenient time slot. At this point, he would wear the supplied chest strap by wetting it appropriately so that it adhered perfectly to the skin. The heart rate App was accessed via Bluetooth and recorded the basal heart rate for about 10 minutes.Then the Mindfulness session was carried out. At the end of 9 days, the completed input tests plus the heart rate measurement were sent on day 10, except for the Mindfulness session, which was not scheduled. After two weeks, the measurement was repeated with the same procedure.
Group 2
Patients in this group met the inclusion criteria and did not take any measurements. They underwent only the neuropsychological evaluation
Interventions
Mindfulness (MCBT) practices were offered to patients with the aim of fostering the elderly's pro-active role in health prevention by making them aware of the relationship between thoughts, emotions and symptomatology of the disorder. The exercises will also be used as a motivational work tool within a protocol of Acceptance and Commitment Therapy (ACT), a new generation cognitive behavioral approach, in which "commitment" components are added to mindfulness, suitable for lifestyle modification.
Eligibility Criteria
Forty subjects (20 adult subjects for the experimental group and 20 adult subjects for the control group) were recruited from the Bonino-Pulejo Neurolesi Center in Messina, Italy.
You may qualify if:
- \- Age of subjects: 50-85 years
- Subjects with global cognitive functioning at normal limits (mmse ≥ 20)
- Subjects with diagnosed mild and/or absent depression;
You may not qualify if:
- Diagnosis of dementia
- Diagnosis of moderate/severe depression
- Language disorders
- Psychiatric disorders
- Praxic deficits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Centro Neurolesi "Bonino-Pulejo"
Messina, 98124, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurologist
Study Record Dates
First Submitted
March 13, 2023
First Posted
March 27, 2023
Study Start
July 27, 2022
Primary Completion
December 27, 2022
Study Completion
December 31, 2022
Last Updated
March 27, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
Corresponding author